{"id":32427,"date":"2020-07-21T15:20:01","date_gmt":"2020-07-21T14:20:01","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32427"},"modified":"2023-04-28T17:24:52","modified_gmt":"2023-04-28T16:24:52","slug":"dairine-dempsey","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/biosimilars-biologics-2017-speakers\/dairine-dempsey\/","title":{"rendered":"Dairine Dempsey"},"content":{"rendered":"
\n\n\t

Dairine Dempsey<\/h2>\n

CEO & co-founder at Open Orphan DAC<\/h4>\n\t

Dr. Dairine Dempsey is the CEO\/CMO & a co-founder of Open Orphan DAC, a Dublin-based EU pharmaceutical company specialised in bringing orphan drugs to EU patients.<\/p>\n

Dairine has over 15 years experience in the pharmaceutical industry including almost 10 years in the national regulatory authority for medicines (now the Health products Regulatory Authority).<\/p>\n

She previously held the role of Vice President ,Strategic Regulatory Affairs at ICON plc, a global clinical research organisation running clinical trials and providing a variety of pharmaceutical services to the medicines and medical device industries worldwide.<\/p>\n

From 2009 to early 2015 Dair\u00edne worked as a pharmaceutical consultant with The Compliance Group with responsibility for pre- and post-marketing regulatory affairs and pharmacovigilance.<\/p>\n

During that time she led the establishment of the pharmaceutical products regulatory authority in Bahrain. Dairine holds a PhD and a pharmacy degree from Trinity College Dublin.<\/p>\n\t\t\t\t\t\t\t\"Dairine_Dempsey_Headshot_Open_Orphan_profile\"\t\t\t\t\t\t\t\n

\n\tTitle: Overview of the regulatory Landscape for Biologics and Biosimilars\n\t<\/h3>\n